ZYNRELEF for Pain Management in Total Knee Arthroplasty
Conditions: Post Operative Pain; Osteoarthritis, Knee Intervention: Drug: Bupivacaine-Meloxicam 400 Mg-12 Mg/14 mL Injectable Solution, Extended Release Sponsor: Baptist Health South Florida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials